Research Management and Impact Tool (ReMIT)

Birgit Schramm

Epicentre

Studies

Status: Completion

Enhanced monitoring of tenofovir-lamivudine-dolutegravir (TLD) replacing first-line HIV-antiretroviral treatment in Chiradzulu District, Malawi (EMEDT)

Study details: Observational study in Malawi

Principal investigator: Birgit Schramm

Latest update: Document added | 23rd September 2024

Status: Completion

Prevalence of active HCV infection and associated risk factors among members of Forcibly Displaced Myanmar National (FDMN) Population residing in camps, Cox's Bazar, Bangladesh

Study details: Observational study in Bangladesh

Principal investigator: Birgit Schramm

Latest update: Document added | 25th November 2024

Status: Completion

Proof-of-concept: Does the TB-LAM urine test have a potential value in the diagnosis of severely acute malnourished (SAM) children with suspicion of tuberculosis?

Study details: Observational study in Niger

Principal investigator: Birgit Schramm

Latest update: 17th February 2025

Status: Concept

Effectiveness, feasibility and acceptability of MFS’s community-based Hepatitis C test and treat campaign for Rohingya refugee population residing in camps in Cox’s Bazar, Bangladesh

Study details: Mixed-methods study in Bangladesh

Principal investigator: Birgit Schramm

Latest update: Study created | 29th December 2025